EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Determinants of clinical severity in children with sickle cell disease and confirmed asthma

Gabriel Bafunyembaka iD, Mathieu Nacher, Ariel Makembi iD, Nadia Nathan iD, Narcisse Elenga

PLOS One · 28.04.2026 · 21 (4) · e0343757

DOI: 10.1371/journal.pone.0343757 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 28.04.2026. Verfasst von Gabriel Bafunyembaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Centre Hospitalier de l'Ouest Guyanais (CHOG), Franck Joly Hospital, Saint-Laurent-du-Maroni, French Guiana, France. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Asthma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma is a frequent comorbidity in children with sickle cell disease and has been associated with an increased risk of acute complications, particularly vaso-occlusive crises and acute chest syndrome. However, determinants of clinical severity among children with sickle cell disease and confirmed asthma remain poorly characterized, especially in tropical settings. This study aimed to identify factors associated with clinical severity in this population.

Methods

We conducted an observational study among children with sickle cell disease followed in French Guiana. The analysis was restricted to children with confirmed asthma. Clinical severity was defined as the occurrence of at least two hospitalizations during the 12 months preceding evaluation for vaso-occlusive crises and/or acute chest syndrome. Factors associated with severity were assessed using univariate and multivariate logistic regression analyses.

Results

A total of 138 children with sickle cell disease and confirmed asthma were included, of whom 102 (73.9%) presented a severe clinical form. In multivariate analysis, no variable was independently associated with clinical severity. However, a trend toward an increased risk of severe disease was observed among children living in rural areas (adjusted OR = 1.94; 95% CI: 0.77–4.86), while a trend toward a protective effect was observed for Strongyloides stercoralis infection (adjusted OR = 0.18; 95% CI: 0.02–1.51). Allergic sensitization, although frequent (64.5%), was not associated with clinical severity after adjustment (adjusted OR = 0.66; 95% CI: 0.31–1.44).

Conclusion

Among children with sickle cell disease and confirmed asthma, more than one third experience severe clinical disease. No independent predictors of severity were identified. Observed trends should be interpreted cautiously and considered exploratory. These findings support a stratified approach to sickle cell–associated asthma to identify high-risk children and prevent avoidable acute complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellAsthmaHumansMaleFemaleChildSeverity of Illness IndexChild, PreschoolVaso-Occlusive CrisesAdolescentRisk FactorsFrench Guiana

Autor:innen und Institutionen

  • Department of Pediatrics, Centre Hospitalier de l'Ouest Guyanais (CHOG), Franck Joly Hospital, Saint-Laurent-du-Maroni, French Guiana, France.
  • Department of Pediatrics, General Reference Hospital of Bukavu, Bukavu, Democratic Republic of the Congo.
  • Clinical Investigation Center, Epidemiology/Public Health (Inserm 1424/CIC), Cayenne Hospital, Cayenne, French Guiana, France.
  • Department of Internal Medicine, Centre Hospitalier de l'Ouest Guyanais (CHOG), Franck Joly Hospital, Saint-Laurent-du-Maroni, French Guiana, France.
  • Pediatric Pulmonology Department, Hôpital Trousseau, AP-HP, Sorbonne Université, Paris, France.
  • Department of Pediatrics, Cayenne Hospital, Cayenne, French Guiana, France.

ORCID-Profile: Gabriel Bafunyembaka, Ariel Makembi, Nadia Nathan

Zitieren

APA

Bafunyembaka, G., Nacher, M., Makembi, A., Nathan, N., & Elenga, N. (2026). Determinants of clinical severity in children with sickle cell disease and confirmed asthma. PLOS One, 21(4), e0343757. https://doi.org/10.1371/journal.pone.0343757

Vancouver

Bafunyembaka G, Nacher M, Makembi A, Nathan N, Elenga N. Determinants of clinical severity in children with sickle cell disease and confirmed asthma. PLOS One. 2026;21(4):e0343757. doi:10.1371/journal.pone.0343757

BibTeX
@article{Bafunyembaka2026,
  author = {Bafunyembaka, Gabriel and Nacher, Mathieu and Makembi, Ariel and Nathan, Nadia and Elenga, Narcisse},
  title = {Determinants of clinical severity in children with sickle cell disease and confirmed asthma},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0343757},
  doi = {10.1371/journal.pone.0343757}
}
Kostenlos starten →